Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
Maud Lemoine(St Mary's Hospital), Mark Thursz(St Mary's Hospital), Jessica Howell(St Mary's Hospital), Shevanthi Nayagam(Imperial College Healthcare NHS Trust), Umberto D’Alessandro(MRC Unit the Gambia), Isabelle Chemin(Inserm), Adam Jeng(MRC Unit the Gambia), Coumba Touré‐Kâne(Hôpital Aristide Le Dantec), A. Sow(Hôpital Aristide Le Dantec), William Stanger(St Mary's Hospital), Simon D. Taylor‐Robinson(Imperial College London), Abdullah Jatta(MRC Unit the Gambia), Harr Freeya Njai(MRC Unit the Gambia), Aboubacar Kambi(MRC Unit the Gambia), Gibril Ndow(MRC Unit the Gambia), Liliane Mpabanzi(Maastricht University Medical Centre), Souleymane Mboup(Université de Tours), Makie Taal(Ministry of Health and Social Welfare), Tumani Corrah(MRC Unit the Gambia), Hilton Whittle(Centre for Human Genetics), Saydiba Tamba(MRC Unit the Gambia), Maimuna Mendy(Centre international de recherche sur le cancer), Penda Suso(Edward Francis Small Teaching Hospital), Ousman Nyan, Louise Sarr(MRC Unit the Gambia), Ramou Njie(MRC Unit the Gambia), Yusuke Shimakawa(Institut Pasteur)
Cited by 182
Related Papers
Bulletin of the World Health Organization
|Bulletin of the World Health Organization|2001|7.2k
Cholangiocarcinoma
|The Lancet|2005|1.1k
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
|Journal of Hepatology|2002|592